Notes And Other Explanatory Information [Abstract]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept 2023-01-01 to
2023-12-31
Notes and other explanatory information [abstract]
Disclosure of allowance for credit losses [text block]
2,023
Disclosure of auditors' remuneration [text block]
Disclosure of borrowings [text block]
Loans
Disclosure of cash and cash equivalents [text block]
Disclosure of changes in accounting policies, accounting estimates and errors [text block]
Disclosure of collateral [text block]
Disclosure of commitments and contingent liabilities [text block]
Disclosure of credit risk [text block]
(d) Credit risk
Disclosure of deferred taxes [text block]
Disclosure of depreciation and amortisation expense [text block]
Disclosure of earnings per share [text block]
2,023
Disclosure of employee benefits [text block]
Disclosure of events after reporting period [text block]
Disclosure of expenses [text block]
Disclosure of finance income [text block]
Disclosure of financial risk management [text block]
Disclosure of going concern [text block]
Disclosure of government grants [text block]
Disclosure of impairment of assets [text block]
Disclosure of income tax [text block]
Disclosure of information about key management personnel [text block]
Board of Directors
Disclosure of intangible assets [text block]
Disclosure of interest expense [text block]
Disclosure of inventories [text block]
Disclosure of issued capital [text block]
Disclosure of liquidity risk [text block]
(e) Liquidity risk
Disclosure of objectives, policies and processes for managing capital [text block]
Capital risk management
Disclosure of other non-current assets [text block]
Disclosure of property, plant and equipment [text block]
Disclosure of related party [text block]
As at 31.12.2023, the following companies are included in the Group:
Disclosure of reserves within equity [text block]
Disclosure of revenue [text block]
Disclosure of subsidiaries [text block]
SS
Disclosure of tax receivables and payables [text block]

Talk to a Data Expert

Have a question? We'll get back to you promptly.